Pipeline & Programs

Pipeline

Solid has a diversified pipeline across neuromuscular and cardiac diseases with indications we believe are characterized by high unmet need, clear mechanistic rationale, and significant market opportunities

  • Research/
    Discovery
  • Preclinical
  • IND Submission
  • Phase I/II
  • Phase III

Neuromuscular

SGT-003 Duchenne

  • Research/
    Discovery
  • Preclinical
  • IND Submission
  • Phase I/II
  • Phase III

SGT-212 Friedreich's ataxia

  • Research/
    Discovery
  • Preclinical
  • IND Submission
  • Phase I/II
  • Phase III

Cardiac

SGT-501 RYR2-Mediated CPVT

  • Research/
    Discovery
  • Preclinical
  • IND Submission
  • Phase I/II
  • Phase III

SGT-501 CASQ2-Mediated CPVT

  • Research/
    Discovery
  • Preclinical
  • IND Submission
  • Phase I/II
  • Phase III

SGT-601 TNNT2 DCM

  • Research/
    Discovery
  • Preclinical
  • IND Submission
  • Phase I/II
  • Phase III

SGT-401 BAG3-Mediated DCM

  • Research/
    Discovery
  • Preclinical
  • IND Submission
  • Phase I/II
  • Phase III

SGT-701 RBM20 DCM

  • Research/
    Discovery
  • Preclinical
  • IND Submission
  • Phase I/II
  • Phase III

Mayo Clinic Collaboration
Six Undisclosed Targets

  • Research/
    Discovery
  • Preclinical
  • IND Submission
  • Phase I/II
  • Phase III

Platform

Capsid Library

  • Research/
    Discovery
  • Preclinical
  • IND Submission
  • Phase I/II
  • Phase III
As we move forward, we expect to see a diversified pipeline, including emerging technologies that will be evaluated for their potential to target underlying diseases and bring groundbreaking genetic therapies to more patients.
Following is the jquery code that sets the body class to the page without a photo hero